Small Cell Lung Carcinoma: all 1,234 studies
Page 1 of 13. Open to participants first (350), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLCNot yet recruitingNCT07892625Phase 1
- Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung CancerNot yet recruitingNCT07892300Early Phase 1
- A Phase 1 Study of IM-1340 in Participants With Advanced CancerNot yet recruitingNCT07890246Phase 1
- Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung CancerRecruitingNCT07886047Phase 1
- Effectiveness and Safety of MRG003 (Becotatug Vedotin) in Relapsed SCLCRecruitingNCT07874581Not applicable
- Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic)RecruitingNCT07864207Phase 1/2
- A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)RecruitingNCT07843940Phase 1/2
- Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLCNot yet recruitingNCT07819591Phase 2
- Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance StatusRecruitingNCT07803848Phase 2
- A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung CancerNot yet recruitingNCT07802821Phase 3
- A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLCRecruitingNCT07798947Phase 2
- A Study of ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung CancerNot yet recruitingNCT07796100Phase 3
- Prospective Multiomic Analysis in Small-Cell Lung CancerRecruitingNCT07795411
- A Study of Armored CAR T Cells in People With CancerRecruitingNCT07783477Phase 1
- Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)RecruitingNCT07778316Phase 3
- NK Cells Plus ICI for SCLC MaintenanceRecruitingNCT07759856Phase 2
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)RecruitingNCT07744698Phase 4
- Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)RecruitingNCT07744256Phase 1/2
- A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsRecruitingNCT07730021Phase 1/2
- A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive ChemotherapyNot yet recruitingNCT07728955Phase 3
- TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid TumorsRecruitingNCT07713732Phase 1
- DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot yet recruitingNCT07707895Phase 1/2
- DLL3-Targeted PET/CT in Small Cell Lung CancerRecruitingNCT07677787Not applicable
- Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line ChemoimmunotherapyNot yet recruitingNCT07670442
- A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung CancerRecruitingNCT07654400Phase 2
- A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)RecruitingNCT07652736
- THE-0504 in Patients With Solid TumorsRecruitingNCT07646106Phase 1
- Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung CancerNot yet recruitingNCT07640932Phase 2
- Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung CancerNot yet recruitingNCT07637513Phase 3
- QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung CancerNot yet recruitingNCT07636226Phase 2/3
- BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)RecruitingNCT07625644Phase 3
- A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Not yet recruitingNCT07623642Phase 2
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled StudyRecruitingNCT07583511Phase 2
- Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive TreatmentRecruitingNCT07565532
- A Study to Evaluate DJI136, a DLL3-targeted CAR-T TherapyRecruitingNCT07564401Phase 1/2
- A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.RecruitingNCT07559929Phase 1/2
- Safety and Preliminary Activity of BI115 in Advanced SCLCRecruitingNCT07559019Phase 1
- 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
- SMARCA4/2 Inhibitor for POU2F3-Positive SCLCNot yet recruitingNCT07551635Phase 2
- A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung CancerNot yet recruitingNCT07550842Phase 1
- Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck OncologyNot yet recruitingNCT07550049
- A Lay Navigation Intervention for Patients With Lung CancerNot yet recruitingNCT07548788Not applicable
- Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLCNot yet recruitingNCT07547332Phase 2
- DSP-0390 in Combination With Atezolizumab for Small Cell Lung CancerRecruitingNCT07545954Phase 1
- A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung CancerNot yet recruitingNCT07538271Phase 2
- Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung CancerNot yet recruitingNCT07538258Phase 2
- Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)RecruitingNCT07531095Phase 1
- Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological TreatmentRecruitingNCT07529145
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsRecruitingNCT07517198Phase 1
- Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor TislelizumabRecruitingNCT07510724
- MDT-Based Umbrella Decision Model for Geriatric Lung Cancer PatientsRecruitingNCT07509333Not applicable
- Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory DiseaseRecruitingNCT07509034Phase 1
- 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung CancerRecruitingNCT07508852Phase 1/2
- A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)RecruitingNCT07502300Phase 3
- Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)Not yet recruitingNCT07501169Phase 2
- A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)RecruitingNCT07488923Phase 1
- A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsRecruitingNCT07488676Phase 1/2
- A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung CancerNot yet recruitingNCT07485920Phase 4
- Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)RecruitingNCT07480213Phase 1/2
- Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerRecruitingNCT07476287Phase 2
- SYS6090 Combination Therapy in Advanced Lung CancerNot yet recruitingNCT07472647Phase 1/2
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- SCLC Tarlatamab Blood CollectionNot yet recruitingNCT07468656
- A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)RecruitingNCT07465757Phase 2
- A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCRecruitingNCT07459634Phase 2
- AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsRecruitingNCT07454642Phase 1
- A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLCRecruitingNCT07434518
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07424547Phase 1
- Tarlatamab for the Treatment of Extensive Stage Small-cell Lung CancerRecruitingNCT07423585Phase 2
- A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI TherapyNot yet recruitingNCT07414927Phase 1/2
- A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsRecruitingNCT07407933Phase 1/2
- Tarlatamab for SCLC Brain MetastasesRecruitingNCT07402343Phase 2
- Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical StudyNot yet recruitingNCT07398560Phase 2
- A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous DurvalumabRecruitingNCT07391670Phase 1
- YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung CancerEnrolling by invitationNCT07390565Not applicable
- Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLCNot yet recruitingNCT07388875Phase 2
- Lung Cancer Screening in Population Who Had Never SmokedNot yet recruitingNCT07383454Not applicable
- Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionNot yet recruitingNCT07376499Phase 2
- A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)RecruitingNCT07373964Phase 2
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruitingNCT07365241Phase 3
- A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung CancerRecruitingNCT07358676Phase 2
- Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRDNot yet recruitingNCT07357532Phase 2
- Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung CancerRecruitingNCT07339059Phase 2
- A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung CancerRecruitingNCT07325136Phase 1/2
- Expanded Access to ABBV-706AvailableNCT07310277
- SKB500 Combinations in Patients With Small Cell Lung CancerRecruitingNCT07296809Phase 2
- Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsRecruitingNCT07278479Phase 1/2
- EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCERRecruitingNCT07267000Not applicable
- A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung CancerRecruitingNCT07253142Phase 2
- This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.RecruitingNCT07249879Phase 1
- TC-D101 Cell Therapy for Patients With DLL3-Positive SCLCRecruitingNCT07246304Early Phase 1
- A Study of Ivonescimab in First-Line ES-SCLCRecruitingNCT07245446Phase 2
- Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLCRecruitingNCT07244016
- Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)RecruitingNCT07243132
- Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC PatientsRecruitingNCT07242547Phase 2
- Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung CancerRecruitingNCT07231445Phase 1
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 1